We are live on ! Find out more
LJHT

Laurie J. Hall Trustee Portfolio holdings

AUM $322M
1-Year Est. Return 33.73%
This Fund
S&P 500
This Quarter Est. Return
+3.38%
1 Year Est. Return
+33.73%
3 Year Est. Return
+96.04%
5 Year Est. Return
+120.73%
10 Year Est. Return
–
AUM
$193M
AUM Growth
+$2.77M
Cap. Flow
-$1.09M
Cap. Flow %
-0.56%
Top 10 Hldgs %
35.31%
Holding
340
New
3
Increased
28
Reduced
67
Closed
8

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$1.07M
2
DD icon
DuPont de Nemours
DD
+$807K
3
XYL icon
Xylem
XYL
+$702K
4
NYT icon
New York Times
NYT
+$670K
5
ROK icon
Rockwell Automation
ROK
+$554K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.2M
2
XLNX
Xilinx Inc
XLNX
+$481K
3
MSFT icon
Microsoft
MSFT
+$420K
4
PEP icon
PepsiCo
PEP
+$373K
5
SYK icon
Stryker
SYK
+$282K

Sector Composition

Rank Sector Weight
1 Healthcare 25.24%
2 Technology 19.8%
3 Industrials 10.75%
4 Consumer Staples 9.98%
5 Financials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BID
301
DELISTED
Sotheby's
BID
$5K ﹤0.01%
90
-60
-40% -$2.51K
FARO
302
DELISTED
Faro Technologies
FARO
$4K ﹤0.01%
+70
New +$3.54K
GRPN icon
303
Groupon
GRPN
$1.06B
$4K ﹤0.01%
52
– –
MGNX icon
304
MacroGenics
MGNX
$243M
$4K ﹤0.01%
210
– –
MYGN icon
305
Myriad Genetics
MYGN
$283M
$4K ﹤0.01%
160
– –
SSP icon
306
E.W. Scripps
SSP
$258M
$4K ﹤0.01%
270
– –
ICPT
307
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$4K ﹤0.01%
50
– –
PTLA
308
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$4K ﹤0.01%
150
+50
+50% +$1.57K
ALDR
309
DELISTED
Alder Biopharmaceuticals
ALDR
$4K ﹤0.01%
300
– –
ISCA
310
DELISTED
International Speedway Corp
ISCA
$4K ﹤0.01%
80
– –
GCI
311
DELISTED
Gannett Co., Inc
GCI
$4K ﹤0.01%
475
– –
ESPR
312
DELISTED
Esperion Therapeutics
ESPR
$3K ﹤0.01%
70
– –
PTCT icon
313
PTC Therapeutics
PTCT
$5.71B
$3K ﹤0.01%
70
– –
UCTT
314
Ultra Clean Holdings
UCTT
$4B
$3K ﹤0.01%
180
– –
UFI icon
315
UNIFI
UFI
$119M
$3K ﹤0.01%
150
– –
VTR icon
316
Ventas
VTR
$47.1B
$3K ﹤0.01%
50
– –
PGNX
317
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$3K ﹤0.01%
520
– –
CC icon
318
Chemours
CC
$2.54B
$2K ﹤0.01%
87
– –
CYTK icon
319
Cytokinetics
CYTK
$10.3B
$2K ﹤0.01%
220
– –
JD icon
320
JD.com
JD
$44.6B
$2K ﹤0.01%
50
– –
JWN
321
DELISTED
Nordstrom
JWN
$2K ﹤0.01%
70
– –
TPC
322
Tutor Perini Cor
TPC
$4.5B
$2K ﹤0.01%
170
– –
LGF.B
323
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$2K ﹤0.01%
191
– –
TWTR
324
DELISTED
Twitter, Inc.
TWTR
$2K ﹤0.01%
50
– –
PRSP
325
DELISTED
Perspecta Inc. Common Stock
PRSP
$2K ﹤0.01%
83
-20
-19% -$449
10 11 12
13
14

Similar funds

EC
Edenbrook Capital Mt. Kisco, New York $321M AUM 79.21% 1-Year Est. Return
BEP
Bluescape Energy Partners Dallas, Texas $322M AUM 18.33% 1-Year Est. Return
WHAM
Windmill Hill Asset Management Waddesdon, United Kingdom $321M AUM 25.22% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
GIM
Gold Investment Management Edmonton, Alberta, Canada $323M AUM 38.72% 1-Year Est. Return
SAMT
Select Asset Management & Trust Mechanicsburg, Pennsylvania $320M AUM 18.83% 1-Year Est. Return
FPL
Fortress Private Ledger Raleigh, North Carolina $320M AUM 45.16% 1-Year Est. Return
SGF
Stephens Greth Foundation Dallas, Texas $320M AUM

Laurie J. Hall Trustee's Q2 2019 Portfolio in Review

As of Q2 2019, Laurie J. Hall Trustee held 340 positions worth $193M, up 1.5% from $190M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q2 2019: portfolio turnover was 3.2%. Laurie J. Hall Trustee opened 3 new positions and exited 8, leaving the 340-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • Laurie J. Hall Trustee's largest Q2 2019 buy was Dow Inc: 4,858 shares worth $240K.
  • Laurie J. Hall Trustee added most to Becton Dickinson in Q2 2019, an estimated $1.07M increase.
  • Laurie J. Hall Trustee's biggest Q2 2019 reduction was AbbVie, cutting an estimated $1.2M.
  • Laurie J. Hall Trustee fully exited iShares Core S&P Mid-Cap ETF in Q2 2019, selling an estimated $34K.
  • Laurie J. Hall Trustee's ten largest holdings make up 35% of its $193M portfolio in Q2 2019.
  • Laurie J. Hall Trustee opened 3 new positions and closed 8 in Q2 2019.
  • Laurie J. Hall Trustee's portfolio value rose 1.5% quarter-over-quarter to $193M.

Based on Laurie J. Hall Trustee's 13F filing for Q2 2019, filed 1 Aug 2019.